Free Trial

Tristel Interim Earnings Report

Tristel logo
GBX 282.60 -2.40 (-0.84%)
As of 12:36 PM Eastern

Tristel EPS Results

Actual EPS
GBX 8.17
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Tristel Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tristel Announcement Details

Quarter
Interim
Time
Before Market Opens

Conference Call Resources

Remove Ads

Tristel Earnings Headlines

[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
See More Tristel Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tristel? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tristel and other key companies, straight to your email.

About Tristel

Tristel (LON:TSTL) is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com

View Tristel Profile

More Earnings Resources from MarketBeat